Creating guidelines for prostate cancer care using expert opinions
Key Elements for Standardized Reporting in Prostate Cancer Management: An Expert Delphi Consensus Study
This study is trying to create clear guidelines for prostate cancer care by gathering opinions from experts to help doctors provide better and more consistent treatment for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10 (estimated) |
| Ages | 21 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Drugs / interventions | Radiation |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT05054413 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish consensus guidelines for key clinical elements in prostate cancer care through a remote Delphi method. A panel of certified experts in relevant fields will participate in multiple rounds of questionnaires to identify essential data elements for standardized reporting in electronic health records. The goal is to enhance the management of prostate cancer patients from diagnosis through survivorship by ensuring consistency in the information recorded. The study emphasizes the importance of expert input in developing these guidelines to improve patient care.
Who should consider this trial
Good fit: Ideal candidates for this study are board-certified medical providers actively treating prostate cancer patients.
Not a fit: Patients who are not medical providers or those who do not treat prostate cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved standardization in prostate cancer care, enhancing patient management and outcomes.
How similar studies have performed: While similar consensus-building approaches have been utilized in other areas of cancer care, this specific application using the Delphi method for prostate cancer is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 21 and above * Board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology * Maintenance of an active practice that includes prostate cancer patients * English speaking Exclusion Criteria: * Medical providers that are not board certified in the professions and/or those who do not treat prostate cancer * Prisoners, children, and adults unable to consent to participation will also be excluded * No exclusions were made based on sex, age, racial/ethnic background, or pregnancy status
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Amy C Moreno — M.D. Anderson Cancer Center
- Study coordinator: Amy C Moreno
- Email: akmoreno@mdanderson.org
- Phone: 713-745-4590
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.